Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.255 USD | -0.40% | +4.90% | +19.89% |
Mar. 19 | Aclaris Therapeutics, Inc. Announces Board Resignations | CI |
Feb. 27 | Aclaris Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Financials (USD)
Sales 2024 * | 7.78M | Sales 2025 * | 8.72M | Capitalization | 89.37M |
---|---|---|---|---|---|
Net income 2024 * | -73M | Net income 2025 * | -100M | EV / Sales 2024 * | 2.33 x |
Net cash position 2024 * | 71.24M | Net cash position 2025 * | 157M | EV / Sales 2025 * | -7.8 x |
P/E ratio 2024 * |
-1.29
x | P/E ratio 2025 * |
-1.06
x | Employees | 89 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.23% |
Latest transcript on Aclaris Therapeutics, Inc.
1 day | +6.78% | ||
1 week | +5.88% | ||
Current month | +5.88% | ||
1 month | +5.00% | ||
3 months | +18.87% | ||
6 months | -81.08% | ||
Current year | +20.00% |
Managers | Title | Age | Since |
---|---|---|---|
Neal Walker
CEO | Chief Executive Officer | 54 | 12-06-30 |
Kevin Balthaser
DFI | Director of Finance/CFO | - | 16-12-31 |
Joseph Monahan
CTO | Chief Tech/Sci/R&D Officer | 68 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Andrew Schiff
BRD | Director/Board Member | 58 | 17-08-08 |
Maxine Gowen
BRD | Director/Board Member | 66 | 19-07-01 |
Andrew Powell
BRD | Director/Board Member | 66 | 17-01-24 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.08% | 0 M€ | 0.00% | - | |
0.08% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 1.26 | 0.00% | 140 283 |
24-03-27 | 1.26 | +6.78% | 1,286,232 |
24-03-26 | 1.18 | +1.72% | 716,343 |
24-03-25 | 1.16 | +0.87% | 586,693 |
24-03-22 | 1.15 | -4.17% | 548,773 |
Delayed Quote Nasdaq, March 27, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+20.00% | 89.37M | |
+9.16% | 45.97B | |
+53.63% | 43.93B | |
+11.20% | 42.34B | |
-8.59% | 28.27B | |
+16.40% | 27.18B | |
-19.34% | 19.44B | |
+13.95% | 13.83B | |
+31.56% | 12.4B | |
+10.63% | 11.45B |